Executive Compensation Linked to Shareholders’ Medium- to Long-Term Interests
First written in FY2017. 9 of 10 entries say "Advanced", first in FY2019-Q2. Latest entry: FY2026-H1.
87 other companies' latest entry also says "Advanced".
- FY2026-H1AdvancedAnnual report
「Resolution date 9 July 2025 Categories and number of grantees 8 directors of the Company 32 executive officers of the Company Number of stock acquisition rights (rights)* 159 Class, terms and number of shares underlying the stock acquisition rights (shares)* Common shares 31,800 Exercise period for the stock acquisition rights* 13 August 2025–12 August 2050」
The Company issued stock acquisition rights equivalent to 31,800 common shares to 8 directors and 32 executive officers, continuing to develop compensation measures linked to shareholders’ medium- to long-term interests. - FY2025-H1AdvancedAnnual report
「Date of resolution 10 July 2024 Categories and number of persons eligible for the grant Company directors 8 people Company executive officers 29 people Number of stock acquisition rights (units)* 152 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 30,400 Exercise period for the stock acquisition rights* 10 August 2024–9 August 2049」
For 8 directors and 29 executive officers, stock acquisition rights representing 30,400 common shares were issued, continuing the compensation measure linked to shareholders’ medium- to long-term interests. - FY2024-Q2AdvancedAnnual report
「Date of resolution 11 July 2023 Categories and number of persons eligible for the grant Company directors 8 people Company executive officers 29 people Number of stock acquisition rights (units)* 155 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 31,000 Exercise period for the stock acquisition rights* 11 August 2023–10 August 2048」
For 8 directors and 29 executive officers, 155 stock acquisition rights representing 31,000 common shares were issued, continuing the compensation measure linked to shareholders’ medium- to long-term interests. - FY2023-Q2AdvancedAnnual report
「Date of resolution 12 July 2022 Categories and number of persons eligible for the grant Company directors 8 people Company executive officers 27 people Number of stock acquisition rights (units)* 150 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 30,000 Exercise period for the stock acquisition rights* 13 August 2022–12 August 2047」
For 8 directors and 27 executive officers, stock acquisition rights representing 30,000 underlying shares were issued, continuing to give concrete form to a compensation measure linked to shareholders’ medium- to long-term interests. - FY2022-Q2AdvancedAnnual report
「Date of resolution 9 July 2021 Categories and number of persons eligible for the grant Company directors 8 people Company executive officers 26 people Number of stock acquisition rights (units)* 146 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 29,200 Exercise period for the stock acquisition rights* 13 August 2021–12 August 2046」
For 8 directors and 26 executive officers, stock acquisition rights representing 29,200 underlying shares were issued, continuing to give concrete form to a compensation measure linked to shareholders’ medium- to long-term interests. - FY2021AdvancedAnnual report
「Compensation for internal directors comprises monthly compensation as fixed compensation, bonuses as performance-linked compensation, and stock option-based equity compensation as non-monetary compensation. Individual compensation and other benefits are determined according to responsibilities.」
The compensation policy linked to shareholders’ medium- to long-term interests has been formalized as a decision policy that includes a guideline allocation of approximately 70% fixed compensation and approximately 30% bonuses and stock option-based equity compensation. - FY2021-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Date of resolution 9 July 2020 Categories and number of persons eligible for the grant Company directors 8 people Company executive officers 25 people Number of stock acquisition rights (units)* 145 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 29,000 Exercise period for the stock acquisition rights* 14 August 2020–13 August 2045」
For 8 directors and 25 executive officers, stock acquisition rights representing 29,000 underlying shares were issued, giving concrete form to a compensation policy linked to shareholders’ medium- to long-term interests. - FY2020-Q2AdvancedAnnual report
「The stock acquisition rights issued during the second quarter accounting period are as follows. Date of resolution 9 July 2019 Categories and number of persons eligible for the grant Company directors 10 people Company executive officers 22 people Number of stock acquisition rights (units)* 131 Class, details and number of shares underlying the stock acquisition rights (shares)* Common shares 26,200 Exercise period for the stock acquisition rights* 10 August 2019–9 August 2044」
For 10 directors and 22 executive officers, stock acquisition rights representing 26,200 underlying shares were issued, giving concrete form to a compensation policy linked to shareholders’ medium- to long-term interests. - FY2019-Q2AdvancedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
For 9 directors and 20 executive officers, 122 stock acquisition rights representing 122,000 underlying shares were issued, giving concrete form to an executive compensation policy linked to shareholders’ medium- to long-term interests. - FY2017First statedAnnual report
「Directors’ compensation will be appropriate, fair and balanced, linked to shareholders’ medium- to long-term interests, and designed to further motivate directors to maximize the Company’s corporate value.」
The policy is to structure compensation for internal directors as fixed compensation, bonuses and stock option-based equity compensation, with decisions made following deliberations by the Nomination and Compensation Advisory Committee.